相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The IL-12 cytokine family in cardiovascular diseases
T. van der Heijden et al.
CYTOKINE (2019)
IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14)
Xinyuan Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice
Qingwei Ji et al.
SCIENTIFIC REPORTS (2017)
Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis
Xiaoyu Kan et al.
CARDIOVASCULAR RESEARCH (2016)
IL-35 improves Treg-mediated immune suppression in atherosclerotic mice
Linlin Tao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice
Kunwu Yu et al.
ATHEROSCLEROSIS (2015)
Identification of a Non-Growth Factor Role for GM-CSF in Advanced Atherosclerosis Promotion of Macrophage Apoptosis and Plaque Necrosis Through IL-23 Signaling
Manikandan Subramanian et al.
CIRCULATION RESEARCH (2015)
Hyperlipidemia and cardiovascular disease: inflammation, dyslipidemia, and atherosclerosis
Uwe J. F. Tietge
CURRENT OPINION IN LIPIDOLOGY (2014)
Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice
Tetsuaki Hirase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke
Daniel Engelbertsen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction
Tabassome Simon et al.
EUROPEAN HEART JOURNAL (2013)
Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs
Manikandan Subramanian et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Interleukin-12p35 Deletion Promotes CD4 T-Cell-Dependent Macrophage Differentiation and Enhances Angiotensin II-Induced Cardiac Fibrosis
Yulin Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Low Levels of Circulating CD4+FoxP3+T Cells Are Associated With an Increased Risk for Development of Myocardial Infarction But Not for Stroke
Maria Wigren et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice
Fumitake Usui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Interleukin-27 Receptor Limits Atherosclerosis in Ldlr-/- Mice
Ekaterina K. Koltsova et al.
CIRCULATION RESEARCH (2012)
Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype
Larissa Cardilo-Reis et al.
EMBO MOLECULAR MEDICINE (2012)
Decreased Plasma IL-35 Levels Are Related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases
Yingzhong Lin et al.
PLOS ONE (2012)
Recent Advances on the Role of Cytokines in Atherosclerosis
Hafid Ait-Oufella et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
IL-33 Reduces Macrophage Foam Cell Formation
James E. McLaren et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-35-mediated induction of a potent regulatory T cell population
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2010)
Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques
Sybille Kempe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery-Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells
Raymond E. Eid et al.
CIRCULATION (2009)
The Th17/Treg imbalance in patients with acute coronary syndrome
Xiang Cheng et al.
CLINICAL IMMUNOLOGY (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells
Wanda Niedbala et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis
Adi Mor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
T cells in atherogenesis - For better or for worse?
Anna-Karin L. Robertson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Natural regulatory T cells control the development of atherosclerosis in mice
H Ait-Oufella et al.
NATURE MEDICINE (2006)
Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes
H Methe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart
D Fairweather et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
CJ Binder et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice
P Davenport et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
IFN-γ deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice
SC Whitman et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice
VL King et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
分享论文
